CRISPR/Cas12a-mediated DNA-AgNC label-free logical gate for multiple microRNAs’ assay
Microchimica Acta · 2024
DOI: 10.1007/s00604-024-06452-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2024. Verfasst von Xiaomei Mu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medici…. Hauptthemen laut MEDLINE: MicroRNAs, CRISPR-Cas Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovati…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Mu, X., Li, J., Xiao, S., Huang, Y., Zhao, S., & Tian, J. (2024). CRISPR/Cas12a-mediated DNA-AgNC label-free logical gate for multiple microRNAs’ assay. Microchimica Acta. https://doi.org/10.1007/s00604-024-06452-8
Vancouver
Mu X, Li J, Xiao S, Huang Y, Zhao S, Tian J. CRISPR/Cas12a-mediated DNA-AgNC label-free logical gate for multiple microRNAs’ assay. Microchimica Acta. 2024. doi:10.1007/s00604-024-06452-8
BibTeX
@article{Mu2024,
author = {Mu, Xiaomei and Li, Jinshen and Xiao, Shixiu and Huang, Yong and Zhao, Shulin and Tian, Jianniao},
title = {CRISPR/Cas12a-mediated DNA-AgNC label-free logical gate for multiple microRNAs’ assay},
journal = {Microchimica Acta},
year = {2024},
doi = {10.1007/s00604-024-06452-8}
}
EUVIMED